Fusilev dosing study for treating mucositis in Folotyn patients

By On 13. February 2013 · Leave a Comment · In Spectrum

Stocks DD has an update on Fusilev dosing study for treating mucositis in Folotyn patients -> Link

About John A

Related posts:

  1. Fusilev vs. Wolter Kluwer (WK) I have done some research about the trend in the...
  2. Opdateret Wolter Kluwer (WK) trend for Fusilev Så har vi modtaget September måneds WK salgstal. Det bliver...
  3. Fusilev vs Wolter Kluwer (WK) Nu har vi så fået os WK data for Juli...
  4. SPPI IR Rodman and Renshaw Her lidt kort update fra aftenens IR præsentation fra SPPI,...
  5. SPPI at J. P. Morgan Spectrum Pharmaceuticals præsenterede igår på J. P. Morgan konferencen. Det...
 

Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.